| Literature DB >> 27587467 |
Weiyi Peng1, Jodi A McKenzie1, Patrick Hwu2.
Abstract
New data from Wang and colleagues show that complement C3 suppresses the function of CD8(+) tumor-infiltrating T cells by inhibiting IL10 production, and targeting the complement receptors C3aR and C5aR enhances the antitumor activity of immune checkpoint blockade. Their results not only define a new role of complement receptors as T-cell coinhibitory receptors, but also are useful in the development of novel strategies to improve the effectiveness of cancer immunotherapy. Cancer Discov; 6(9); 953-5. ©2016 AACR.See related article by Wang et al., p. 1022. ©2016 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27587467 PMCID: PMC6069599 DOI: 10.1158/2159-8290.CD-16-0698
Source DB: PubMed Journal: Cancer Discov ISSN: 2159-8274 Impact factor: 39.397